Where does Endophys Holdings, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Endophys Holdings, LLC ranks #26,228 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Endophys Holdings, LLC hold?

Endophys Holdings, LLC holds 10 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Endophys Holdings, LLC's Innovation Score?

Endophys Holdings, LLC has an Innovation Score of 41.9 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Endophys Holdings, LLC focus on?

Endophys Holdings, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 10 patents, ranking #1,719 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Endophys Holdings, LLC's patent grant rate increasing or decreasing?

Endophys Holdings, LLC's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Endophys Holdings, LLC's patents?

Endophys Holdings, LLC's patents average 26.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Endophys Holdings, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Endophys Holdings, LLC

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Endophys ranks #26,228 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#26,228
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 26.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26228 · US Corporation #26,228 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,228/49,997
PHOTO-FINISH Elmo
CPC-NARROW A61B · 6 areas
INNOV-PAR 41.9/100
CLAIMS-DENSE 26.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Elmo Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Endophys’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (20%) Velocity 10.0 pts (24%) Breadth 8.7 pts (21%) Claim depth 15.0 pts (36%)

Qualcomm Incorporated · highest

85
Endophys Holdings · this assignee

42
3D Lighting… · lowest

7

What this shows Endophys's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Endophys?

Each dot is one of Endophys’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endophys’s own 26.8 claims/patent is ABOVE the 18.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Endophys vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Endophys's grants concentrate

Endophys Holdings, LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2015. By volume, Endophys sits between Elmo Co., Ltd. and Enpirion, Inc..

Endophys's three-year grant acceleration

Endophys Holdings, LLC shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Elmo

10
Emerald Energy NW

10
Emprimus

10
Enchroma

10
Energy Integration

10
Enforcement Video

10
Enki Technology

10
Enpirion

10
Endophys Holdings ◀

10

What this shows Endophys holds 10 patents at rank #26,251, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Endophys

By rank, the assignees closest to #26,251 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Endophys's primary technology class.

Endophys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Endophys Holdings, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2017	1	10.0%
2018	1	10.0%
2019	1	10.0%
2020	1	10.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	2	20.0%

Which technologies does Endophys Holdings, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 10

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 3

Y10T - Technical Subjects Covered BY Former US Classification 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Endophys Holdings, LLC's patent record in context - here's where to go next.

Endophys Holdings, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #26,228 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Endophys Holdings, LLC against Elmo Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.